Gui‐long Wu

476 total citations
24 papers, 322 citations indexed

About

Gui‐long Wu is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Gui‐long Wu has authored 24 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Biomedical Engineering, 10 papers in Molecular Biology and 10 papers in Materials Chemistry. Recurrent topics in Gui‐long Wu's work include Nanoplatforms for cancer theranostics (16 papers), Advanced Nanomaterials in Catalysis (9 papers) and Photodynamic Therapy Research Studies (8 papers). Gui‐long Wu is often cited by papers focused on Nanoplatforms for cancer theranostics (16 papers), Advanced Nanomaterials in Catalysis (9 papers) and Photodynamic Therapy Research Studies (8 papers). Gui‐long Wu collaborates with scholars based in China and United States. Gui‐long Wu's co-authors include Qinglai Yang, Xiaofeng Tan, Na Li, Sha Yang, Li Tang, Peixian Wu, Wei Zhou, Hao Xiao, Fen Liu and Minghui Wang and has published in prestigious journals such as Angewandte Chemie International Edition, Analytical Chemistry and Chemical Engineering Journal.

In The Last Decade

Gui‐long Wu

23 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gui‐long Wu China 10 241 153 92 71 33 24 322
Sha Yang China 10 202 0.8× 120 0.8× 95 1.0× 67 0.9× 29 0.9× 26 309
Jiantao Ping China 11 165 0.7× 125 0.8× 119 1.3× 51 0.7× 27 0.8× 26 331
Miaozhuang Fan China 10 242 1.0× 208 1.4× 67 0.7× 68 1.0× 22 0.7× 20 332
Bhaskar Gurram China 11 192 0.8× 171 1.1× 88 1.0× 81 1.1× 31 0.9× 27 386
Aiyan Ji China 10 367 1.5× 228 1.5× 103 1.1× 62 0.9× 62 1.9× 18 479
Kaiqi Long Hong Kong 13 200 0.8× 147 1.0× 85 0.9× 41 0.6× 50 1.5× 25 340
Xiaofeng Tan China 14 277 1.1× 206 1.3× 129 1.4× 75 1.1× 46 1.4× 38 479
Yongkuan Suo China 10 291 1.2× 145 0.9× 95 1.0× 65 0.9× 55 1.7× 14 368
Chenyi Huang China 10 306 1.3× 194 1.3× 137 1.5× 62 0.9× 74 2.2× 12 456

Countries citing papers authored by Gui‐long Wu

Since Specialization
Citations

This map shows the geographic impact of Gui‐long Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gui‐long Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gui‐long Wu more than expected).

Fields of papers citing papers by Gui‐long Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gui‐long Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gui‐long Wu. The network helps show where Gui‐long Wu may publish in the future.

Co-authorship network of co-authors of Gui‐long Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Gui‐long Wu. A scholar is included among the top collaborators of Gui‐long Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gui‐long Wu. Gui‐long Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiong, Jian, Baoliang Zhao, Chuanfu Li, et al.. (2025). Conversion therapy strategy: A novel GPC3-targeted multimodal organic phototheranostics platform for mid-late-stage hepatocellular carcinoma. Materials Today Bio. 30. 101442–101442. 1 indexed citations
2.
Wu, Yingying, Xiaofeng Tan, Hongyu Gong, et al.. (2025). Self-assembled TMB-CuO2 nanosheets for dual-mode colorimetric and NIR-II photothermal detection of uranyl ion. Analytica Chimica Acta. 1356. 344041–344041. 2 indexed citations
3.
Wu, Gui‐long, et al.. (2025). Unimolecular Micellization Strategy for Achieving NIR‐II Excited Fluorophores with Enhanced Brightness in Aqueous Media. Angewandte Chemie International Edition. 65(6). e14722–e14722.
4.
5.
Kang, Qiang, Fen Liu, Zelong Li, et al.. (2025). Molecular Engineering of NIR-II Excitable Phototheranostic for Mitochondria-Targeted Cancer Photoimmunotherapy. Journal of Medicinal Chemistry. 68(7). 7707–7719. 2 indexed citations
6.
Wu, Juan, Xiaofeng Tan, Yu Liu, et al.. (2024). NIR-activated water-soluble molecular probe based on Cu(ii) ion quenching mechanisms and substituted strategies: For in vitro/in vivo H2S detection. Sensors and Actuators B Chemical. 415. 135875–135875. 4 indexed citations
7.
Wu, Gui‐long, et al.. (2024). Illuminating the future: NIR-II visualizes gas therapy for precision cancer treatment. Medical Gas Research. 14(4). 172–174. 1 indexed citations
8.
Wu, Gui‐long, et al.. (2024). Recent advances in ferrocene-based nanomedicines for enhanced chemodynamic therapy. Theranostics. 15(2). 384–407. 8 indexed citations
9.
Yang, Sha, Hao Xiao, Qiang Kang, et al.. (2024). Lysosome-Targeted and pH-Activatable Phototheranostics for NIR-II Fluorescence Imaging-Guided Nasopharyngeal Carcinoma Phototherapy. Bioconjugate Chemistry. 35(7). 1015–1023. 8 indexed citations
10.
Li, Na, Minghui Wang, Fen Liu, et al.. (2024). Bioorthogonal Engineering of Bacterial Outer Membrane Vesicles for NIR-II Fluorescence Imaging-Guided Synergistic Enhanced Immunotherapy. Analytical Chemistry. 96(49). 19585–19596. 9 indexed citations
11.
Wu, Gui‐long, Fen Liu, Na Li, et al.. (2023). Trisulfide Bond‐Mediated Molecular Phototheranostic Platform for “Activatable” NIR‐II Imaging‐Guided Enhanced Gas/Chemo‐Hypothermal Photothermal Therapy. Advanced Science. 10(36). e2304104–e2304104. 48 indexed citations
12.
Pan, Qi, Ke Li, Yafei Wang, et al.. (2023). Rational design of NIR-II molecule-engineered nanoplatform for preoperative downstaging and imaging-guided surgery of orthotopic hepatic tumor. Journal of Nanobiotechnology. 21(1). 489–489. 4 indexed citations
13.
Wu, Peixian, Minghui Wang, Sha Yang, et al.. (2023). Magnetic RuCo aerogels with enhanced peroxidase-like activity by regulation of boron and oxygen vacancies for colorimetric biosensing applications. Microchimica Acta. 190(2). 58–58. 5 indexed citations
14.
Wu, Gui‐long, Xiaofeng Tan, & Qinglai Yang. (2023). Recent Advances on NIR‐II Light‐Enhanced Chemodynamic Therapy. Advanced Healthcare Materials. 13(10). e2303451–e2303451. 25 indexed citations
15.
Yang, Sha, Bin Sun, Fen Liu, et al.. (2023). NIR‐II Imaging‐Guided Mitochondrial‐Targeting Organic Nanoparticles for Multimodal Synergistic Tumor Therapy. Small. 19(26). e2207995–e2207995. 42 indexed citations
16.
Wang, Minghui, Peixian Wu, Sha Yang, et al.. (2023). β-cyclodextrin-modified AuBi metallic aerogels enable efficient peroxidase mimicking for colorimetric sensing of urease-positive pathogenic bacteria. Nano Research. 16(7). 9663–9671. 12 indexed citations
17.
Yang, Sha, Gui‐long Wu, Na Li, et al.. (2022). A mitochondria-targeted molecular phototheranostic platform for NIR-II imaging-guided synergistic photothermal/photodynamic/immune therapy. Journal of Nanobiotechnology. 20(1). 475–475. 38 indexed citations
18.
Yang, Sha, Na Li, Hao Xiao, et al.. (2022). Clearance pathways of near-infrared-II contrast agents. Theranostics. 12(18). 7853–7883. 18 indexed citations
19.
He, Dongxiu, et al.. (2022). Preparation of urchin-like Pd-Pt-Ir nanozymes and their application for the detection of ascorbic acid and hydrogen peroxide. Materials Letters. 314. 131851–131851. 18 indexed citations
20.
Wang, Haixia, Chuan‐Wan Wei, Xiaojuan Wang, et al.. (2020). A facile gelator based on phenylalanine derivative is capable of forming fluorescent Zn-metallohydrogel, detecting Zn2+ in aqueous solutions and imaging Zn2+ in living cells. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 250. 119378–119378. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026